95 related articles for article (PubMed ID: 20432940)
1. [Eukaryotic expression and bioactivity determination of the fusion protein sTNFRII-gAD consisting of soluble tumor necrosis factor receptor II and globular domain of adiponectin].
Chen S; He Q; Dong X; Wu X; Gao J
Sheng Wu Gong Cheng Xue Bao; 2010 Feb; 26(2):207-15. PubMed ID: 20432940
[TBL] [Abstract][Full Text] [Related]
2. [Rapid expression and preparation of the recombinant fusion protein sTNFRII-gAD by adenovirus vector system].
Lu Y; Liu D; Zhang X; Liu X; Shen W; Zheng G; Liu Y; Dong X; Wu X; Gao J
Sheng Wu Gong Cheng Xue Bao; 2011 Aug; 27(8):1239-46. PubMed ID: 22097814
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of a novel trimerized sTNFRII on acute liver injury.
Luo M; Liu D; Zhang L; Huang S; Yang W; Zhang L; Cui T; Ma H; Wang Z; Sun Q; Xiong C; Zhu J; Li J; Wu X; Jin L; Hu Z; Gao J
Int Immunopharmacol; 2012 May; 13(1):88-92. PubMed ID: 22465962
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of two types of cell cultures for preparation of sTNFRII-gAD fusion protein].
Huang S; Yin Y; Xiong C; Wang C; Lü J; Gao J
Sheng Wu Gong Cheng Xue Bao; 2013 Jan; 29(1):115-8. PubMed ID: 23631125
[TBL] [Abstract][Full Text] [Related]
5. Efficient production of sTNFRII-gAD fusion protein in large quantity by use of the modified CHO-S cell expression system.
Cai Q; Zhao A; Yuting Yin ; Ma L; Jiao Z; Zhi H; Lai S; Cheng S; Yang H; Lu Y; Siminovitch KA; Gao J
PLoS One; 2014; 9(10):e111229. PubMed ID: 25340707
[TBL] [Abstract][Full Text] [Related]
6. [Cloning, expression and bio-activity assay of chimeric fusion protein sTNFRII-IgG Fc].
Xu CX; Yao LH; Zu D; Chen AJ; Huang GJ; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):178-81. PubMed ID: 12148279
[TBL] [Abstract][Full Text] [Related]
7. Preventive Effect of a Novel Recombinant sTNFRII on Collagen-Induced Arthritis.
Luo M; Zhao A; Gao H; He L; Guo Y; Tian D; Liu Y; Chen L; Liu P; Hu Z; Gao J
Immunol Invest; 2015; 44(5):470-81. PubMed ID: 26107746
[TBL] [Abstract][Full Text] [Related]
8. [Cloning and expression of human TNFR (P55)-IgG Fc fusion protein in eukaryotic cells].
An N; Xu C; Zhang Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):116-7. PubMed ID: 11436637
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Active Components of the Multimerized sTNFRIIAdiponectin Fusion Protein Showing Both TNFα-Antagonizing and Glucose Uptake-Promoting Activities.
Wang Y; Lian H; Wang X; Zheng T; Yu X; Chen R; Huang Z; Lv Y; Zhao A; Gao J
Endocr Metab Immune Disord Drug Targets; 2020; 20(7):1081-1089. PubMed ID: 31965947
[TBL] [Abstract][Full Text] [Related]
10. Acute liver injury attenuation of a novel recombinant sTNFR through blocking hepatic apoptosis.
Luo M; Zhao A; Li J; Chen Y; Tian D; Wang C; Hu Z; Gao J
Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):295-300. PubMed ID: 25982795
[TBL] [Abstract][Full Text] [Related]
11. [Bioassay of the soluble human tumor necrosis factor receptor I recombinant plasmid expression in vitro].
Xu CR; Zhang JC; Zhao CJ; Zhang YH
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):185-8. PubMed ID: 15196381
[TBL] [Abstract][Full Text] [Related]
12. [Construction and expression of a prokaryotic vector of recombinant human adiponectin global domain].
Pu S; Yu YR; Long Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1614-6. PubMed ID: 18819880
[TBL] [Abstract][Full Text] [Related]
13. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
14. [Construction of adenoviral vector encoding soluble human sTNFRI-IgGFc cDNA and its expression in human airway smooth muscle cells (HASMCs)].
Su J; You C; Cai S; Ma L; Wang X; Wen Q; Luo W; Huang Y
Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):774-9. PubMed ID: 18724696
[TBL] [Abstract][Full Text] [Related]
15. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
[TBL] [Abstract][Full Text] [Related]
16. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
17. Fusion of HSA influences TNF-α neutralizing activity of shTNFRs.
Zhan J; Chen Y; Yuan HY; Li H; Lu H
Biotechnol Lett; 2012 Mar; 34(3):417-23. PubMed ID: 22083716
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
[TBL] [Abstract][Full Text] [Related]
19. [Construction of eukaryotic expression vector of muCD40-IgG1Fc fusion protein and its expression in CHO cells].
Xu J; Qu QX; Zhu YB; Zhang XG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):673-6. PubMed ID: 22768851
[TBL] [Abstract][Full Text] [Related]
20. Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts.
McTiernan CF; Mathier MA; Zhu X; Xiao X; Klein E; Swan CH; Mehdi H; Gibson G; Trichel AM; Glorioso JC; Feldman AM; McCurry KR; London B
Gene Ther; 2007 Dec; 14(23):1613-22. PubMed ID: 17851548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
